Inhalation Drug Product Development and Manufacturing: Information Sheet
Intranasal Drug Product Development and Manufacturing
Webinar: Scaling Up Oral Solid Dose Manufacturing for Late-Phase Success
Does a One-Site CDMO Make a Difference in Drug Development?
A one-site CDMO is where GMP, R&D and manufacturing all operate on one site, making the movement of projects streamlined.
Tech Transfer in Late-Stage Oral Solid Dose Projects: Lessons Learnt and Best Practices from a CDMO Perspective
Tech transfer in oral solid dose (OSD) manufacturing is one of the most critical, and often underestimated, phases in the drug development lifecycle. For CDMOs, it’s a moment where scientific precision meets operational discipline.
Upperton Expands High Precision Filling Capability at Nottingham Facility
Upperton has increased its filling capability with the installation of the Fill2Weight gravimetric powder filling machine from 3P innovation
Upperton Pharma Solutions Awarded VaxHub Sustainable Grant to Advance Oral Vaccine Delivery in Partnership with the University of Oxford’s Pandemic Sciences Institute
Upperton will apply its expertise to enable the next generation of Adenovirus-vectored vaccines to be delivered without needles.
Project Management Spotlight with Sophie Skinner
Discover more about our team. In this Spotlight, meet our Project Coordinator, Sophie Skinner, on her journey with Upperton.
Webinar – Navigating the Sterile Fill Finish CDMO Landscape for Development & Manufacturing Success
Nikki Whitfield, CEO of Upperton Pharma Solutions, Honoured with ‘CEO Excellence in Pharmaceutical Manufacturing’ Award at the CEO Today Global Awards 2025.
Nikki Whitfield, CEO of Upperton, has received the ‘CEO Excellence in Pharmaceutical Manufacturing’ Award at the CEO Today Global Awards 2025